Depreciation of NovaBay Pharmaceuticals, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NovaBay Pharmaceuticals, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the quarter ending 30 Sep 2025 was $1,000, unchanged year-over-year.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $23,000, a 30% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2024 was $40,000, a 22% decline from 2023.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2023 was $51,000, a 58% decline from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2022 was $120,000, a 103% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

NovaBay Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23,000 $1,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $23,000 $1,000 -$7,000 -88% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $30,000 $2,000 -$10,000 -83% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $40,000 $19,000 +$7,000 +58% 01 Oct 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
Q3 2024 $33,000 $1,000 -$12,000 -92% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $45,000 $8,000 -$5,000 -38% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $50,000 $12,000 -$1,000 -7.7% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $51,000 $12,000 01 Oct 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
Q3 2023 $13,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $13,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $13,000 -$17,000 -57% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $30,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q2 2016 $27,000 -$14,000 -34% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 $40,000 -$1,000 -2.4% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q2 2015 $41,000 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $41,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

NovaBay Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $40,000 -$11,000 -22% 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
2023 $51,000 -$69,000 -58% 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
2022 $120,000 +$61,000 +103% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $59,000 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2022 2021 FY
2015 $164,000 -$68,000 -29% 01 Jan 2015 31 Dec 2015 10-K 04 Mar 2016 2015 FY
2014 $232,000 -$82,000 -26% 01 Jan 2014 31 Dec 2014 10-K 04 Mar 2016 2015 FY
2013 $314,000 -$27,000 -7.9% 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY
2012 $341,000 -$84,000 -20% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $425,000 -$2,000 -0.47% 01 Jan 2011 31 Dec 2011 10-K 06 Mar 2014 2013 FY
2010 $427,000 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.